WallStreetZenWallStreetZen

NASDAQ: MNMD
Mind Medicine Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MNMD

Based on 4 analysts offering 12 month price targets for Mind Medicine Inc.
Min Forecast
$20.00+109.86%
Avg Forecast
$38.25+301.36%
Max Forecast
$75.00+686.99%

Should I buy or sell MNMD stock?

Based on 4 analysts offering ratings for Mind Medicine Inc.
Strong Buy
Strong Buy
1 analysts 25%
Buy
3 analysts 75%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MNMD stock forecasts and price targets.

MNMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2024-03-08Find Out Why
lockedlocked$00.00+00.00%2024-03-07Find Out Why

1 of 1

Forecast return on equity

Is MNMD forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is MNMD forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

MNMD revenue forecast

What is MNMD's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$20.2M
Avg 2 year Forecast
$224.7M
Avg 3 year Forecast
$530.3M

MNMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MNMD$9.53$38.25+301.36%Strong Buy
RANI$7.85$9.67+23.15%Strong Buy
CRBP$37.16$52.00+39.94%Strong Buy
LXRX$1.62N/AN/A
NKTX$7.86$17.83+126.88%Strong Buy
View Top Biotech Stocks

Mind Medicine Stock Forecast FAQ

Is Mind Medicine Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: MNMD) stock is to Strong Buy MNMD stock.

Out of 4 analysts, 1 (25%) are recommending MNMD as a Strong Buy, 3 (75%) are recommending MNMD as a Buy, 0 (0%) are recommending MNMD as a Hold, 0 (0%) are recommending MNMD as a Sell, and 0 (0%) are recommending MNMD as a Strong Sell.

If you're new to stock investing, here's how to buy Mind Medicine stock.

What is MNMD's revenue growth forecast for 2026-2028?

(NASDAQ: MNMD) Mind Medicine's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Mind Medicine's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast MNMD's revenue for 2026 to be $834,953,001, with the lowest MNMD revenue forecast at $834,953,001, and the highest MNMD revenue forecast at $834,953,001. On average, 3 Wall Street analysts forecast MNMD's revenue for 2027 to be $9,287,529,443, with the lowest MNMD revenue forecast at $2,814,866,307, and the highest MNMD revenue forecast at $16,570,096,990.

In 2028, MNMD is forecast to generate $21,919,417,665 in revenue, with the lowest revenue forecast at $7,803,917,162 and the highest revenue forecast at $39,225,844,000.

What is MNMD's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: MNMD) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is MNMD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year MNMD price target, the average MNMD price target is $38.25, with the highest MNMD stock price forecast at $75.00 and the lowest MNMD stock price forecast at $20.00.

On average, Wall Street analysts predict that Mind Medicine's share price could reach $38.25 by Apr 15, 2025. The average Mind Medicine stock price prediction forecasts a potential upside of 301.36% from the current MNMD share price of $9.53.

What is MNMD's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: MNMD) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.